Geneos Wealth Management’s Cantel Medical Corporation CMD Stock Holding History

Geneos Wealth Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-40	Closed	-$3K	–	3201
2021 Q1	$3K	Hold	40	–	–	﹤0.01%	2853
2020 Q4	$3K	Hold	40	–	–	﹤0.01%	2666
2020 Q3	$1K	Hold	40	–	–	﹤0.01%	2614
2020 Q2	$1K	Hold	40	–	–	﹤0.01%	2548
2020 Q1	$1K	Hold	40	–	–	﹤0.01%	2459
2019 Q4	$2K	Hold	40	–	–	﹤0.01%	2424
2019 Q3	$3K	Hold	40	–	–	﹤0.01%	2270
2019 Q2	$3K	Hold	40	–	–	﹤0.01%	2281
2019 Q1	$2K	Hold	40	–	–	﹤0.01%	2285
2018 Q4	$2K	Hold	40	–	–	﹤0.01%	2260
2018 Q3	$3K	Hold	40	–	–	﹤0.01%	2230
2018 Q2	$3K	Hold	40	–	–	﹤0.01%	2077
2018 Q1	$4K	Hold	40	–	–	﹤0.01%	1933
2017 Q4	$4K	Hold	40	–	–	﹤0.01%	1912
2017 Q3	$3K	Hold	40	–	–	﹤0.01%	1935
2017 Q2	$3K	Hold	40	–	–	﹤0.01%	1892
2017 Q1	$3K	Hold	40	–	–	﹤0.01%	1845
2016 Q4	$3K	Hold	40	–	–	﹤0.01%	1812
2016 Q3	$3K	Buy	+40	New	+$2.9K	﹤0.01%	1735

Geneos Wealth Management's CMD Position: Q2 2021 in Review

Geneos Wealth Management sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 40 shares — an estimated $3K sold.

Geneos Wealth Management first reported a position in CMD in Q3 2016 and held it in 19 quarters. The position peaked at $4K in Q1 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

Geneos Wealth Management reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
Geneos Wealth Management sold 40 Cantel Medical Corporation shares in Q2 2021, an estimated $3K.
Geneos Wealth Management first reported a position in Cantel Medical Corporation in Q3 2016 and held it in 19 quarters.
Geneos Wealth Management's Cantel Medical Corporation position peaked at $4K in Q1 2018.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Geneos Wealth Management's 13F filing for Q2 2021, filed 8 Jul 2021.